Xtandi (enzalutamide)

pCPA File Number: 20762
Negotiation Status:
Concluded with an LOI
Indication(s):
Metastatic Castration-Resistant Prostate Cancer
Sponsor/Manufacturer:
Astellas Pharma Inc.
CDA-AMC Project Number:
PC0023-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: